A retrospective analysis of eosinophilia as a predictive marker of response and toxicity to cancer immunotherapy

AIM: To investigate eosinophilia as a potential on-treatment biomarker for patients receiving cancer immunotherapy. MATERIALS & METHODS: We evaluated the association between eosinophilia and treatment response and toxicity in a retrospective cohort of patients receiving cancer immunotherapy. RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Tharani, Tomita, Yoko, Roberts-Thomson, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720365/
https://www.ncbi.nlm.nih.gov/pubmed/33312694
http://dx.doi.org/10.2144/fsoa-2020-0070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720365/
https://www.ncbi.nlm.nih.gov/pubmed/33312694
http://dx.doi.org/10.2144/fsoa-2020-0070

Ejemplares similares